CIK 2006045
SymBiosis Capital Partners, LLC
Institutional 13F holdings & portfolio
Holdings
11
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–11 of 11
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| EVMN | Evommune, Inc. | 1.3M | $1M+ | SH |
| VSTM | Verastem Inc | 2.0M | $1M+ | SH |
| AMPG | Aldeyra Therapeutics Inc | 2.6M | $1M+ | SH |
| PGEN | Precigen Inc | 3.0M | $1M+ | SH |
| IVA | Inventiva S.A. | 2.6M | $1M+ | SH |
| NUVB | Nuvation Bio Inc | 1.3M | $1M+ | SH |
| RANI | Rani Therapeutics Holdings, Inc. | 6.3M | $1M+ | SH |
| AARD | Aardvark Therapeutics, Inc. | 477K | $1M+ | SH |
| CLNN | Clene Nanomedicine Inc. | 770K | $1M+ | SH |
| GBIO | Generation Bio Co | 665K | $1M+ | SH |
| SRZNW | Surrozen, Inc. | 150K | $1K–$15K | SH |